Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection

ClinicalTrials.gov ID: NCT00047814

Public ClinicalTrials.gov record NCT00047814. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 7:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multiple Rising-Dose Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection

Study identification

NCT ID
NCT00047814
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
48 participants

Conditions and interventions

Conditions

Interventions

  • FK788 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2002
Primary completion
Not listed
Completion
Feb 28, 2006
Last update posted
Dec 8, 2011

2002 – 2006

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Liver Center Huntington Memorial Hospital Pasadena California 91105
Rocky Mount Gastroenterology Lakewood Colorado 80215
University of Florida and Shands Hospital Gainsville Florida 32610
Liver Center BIDMC - Harvard Boston Massachusetts 02215
Gastroenterology and Hepatology Kansas City Missouri 64131
Carolinas Center for Liver Disease Charlotte North Carolina 28203
Duke University Durham North Carolina 27705
Thomas Jefferson University, Gastroenterology and Hepatology Philadelphia Pennsylvania 19107
Northwest Medical Specialties, PLLC Infections Limited, P.S. Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00047814, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2011 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00047814 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →